$3.24
-0.15 (-4.42%)
Open$3.38
Previous Close$3.39
Day High$3.39
Day Low$3.16
52W High$9.99
52W Low$1.98
Volume—
Avg Volume109.1K
Market Cap29.20M
P/E Ratio—
EPS$-0.87
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,265.1% upside
Current
$3.24
$3.24
Target
$44.23
$44.23
$32.29
$44.23 avg
$55.91
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 16.90M | 15.57M | 15.33M |
| Net Income | 2.99M | 2.88M | 3.11M |
| Profit Margin | 17.7% | 18.5% | 20.3% |
| EBITDA | 3.97M | 4.34M | 3.61M |
| Free Cash Flow | 3.54M | 3.27M | 3.55M |
| Rev Growth | +19.1% | +9.8% | -6.9% |
| Debt/Equity | 0.36 | 0.34 | 0.37 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |